Fig. 4From: MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progressionEffects of miR-23b transfection on the invasive and metastatic ability of ovarian carcinoma cell lines. After transfection with the miR-23b mimic, ovarian carcinoma cells showed a lower migration and b slower invasion as compared with the control and mock-transfected cells. Results are representative of three separate experiments; data are expressed as the mean ± standard deviation, *p < 0.05Back to article page